Kenneth Gordon to Janus Kinase Inhibitors
This is a "connection" page, showing publications Kenneth Gordon has written about Janus Kinase Inhibitors.
Connection Strength
0.163
-
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis. N Engl J Med. 2018 10 04; 379(14):1313-1321.
Score: 0.163
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.